Biomarin Pharmaceutical Inc
XMUN:BM8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
A
|
Axon Enterprise Inc
F:TCS
|
US |
|
U
|
UniFirst Corp
F:U1N
|
US |
|
H
|
Hitachi Ltd
XMUN:HIA1
|
JP |
|
B
|
Boeing Co
XMUN:BCO
|
US |
|
Noble Corp (Cayman Island)
NYSE:NE
|
US |
|
P
|
Pliant Therapeutics Inc
F:9PT
|
US |
|
C
|
Continental AG
MIL:CON
|
DE |
|
W
|
Whitehaven Coal Ltd
OTC:WHITF
|
AU |
|
M
|
Mitsubishi UFJ Financial Group Inc
XMUN:MFZ
|
JP |
|
S
|
Summit Materials Inc
SWB:7SU
|
US |
|
Inpixon
NASDAQ:XTIA
|
US |
|
A
|
Axis Bank Ltd
F:UZC
|
IN |
|
N
|
NP3 Fastigheter AB
F:N33
|
SE |
|
Volvo AB
OTC:VLVLY
|
SE |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
BMV:BBVA
|
ES |
|
C
|
China Resources Land Ltd
XMUN:CHZ
|
HK |
|
Vector Group Ltd
NYSE:VGR
|
US |
|
A
|
Agnico Eagle Mines Ltd
SWB:AE9
|
CA |
|
V
|
Vodacom Group Ltd
JSE:VOD
|
ZA |
|
S
|
Silvercorp Metals Inc
AMEX:SVM
|
CA |
|
C
|
Commerzbank AG
DUS:CBK
|
DE |
|
Covivio SA
F:F5D
|
FR |
Wall St Price Targets
BM8 Price Targets Summary
Biomarin Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for BM8 is 79.64 EUR with a low forecast of 44.09 EUR and a high forecast of 110.01 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BM8's stock price target?
Price Target
79.64
EUR
According to Wall Street analysts, the average 1-year price target for BM8 is 79.64 EUR with a low forecast of 44.09 EUR and a high forecast of 110.01 EUR.
What is the Revenue forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Gross Profit forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
14%
The compound annual growth rate for Operating Income over the next 8 years is 14%.
What is the Pre-Tax Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
51%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 51%.
What is the Net Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
24%
The compound annual growth rate for Net Income over the next 8 years is 24%.
